Campaign India Team
Apr 24, 2025

Havas invests in Ostro's AI platform

This investment in the AI-led platform will support Havas Health Network, boost Havas Creative and Media Networks, and refine the agency's media precision.

Image credit: 
jcomp/Freepik.com
Image credit: jcomp/Freepik.com

Havas has invested in Ostro, an AI-powered digital engagement platform for life sciences brands. This move gives the global advertising company access to the latter's technology for its global ecosystem and offers support for Havas Health Network's clientele. The ad network also plans to extend this access to Havas Creative and Media Networks' content workflows and omnichannel activations to achieve enhanced media precision.

American independent investment banking and financial services company Houlihan Lokey served as the advisor for the deal.

The investment represents the latest in a series of strategic moves by Havas. “By combining creativity with AI-powered intelligence, we are empowering clients to deliver relevant, personalised, and compliant experiences at scale,” said Donna Murphy, global CEO of Havas Health & Creative Networks.

Ostro claims that many of the top 10 global biopharma companies are its clients and its platform adoption is also accelerating across mid-sized pharma and emerging biotech organisations. According to a company press release, the platform supports engagement that adjusts to every phase in a patient's healthcare journey.

“Ostro was built to make healthcare engagement more intuitive and personalised. Partnering with Havas gives us a global platform to scale,” said Dr Chase Feiger, CEO & co-founder, Ostro.

Stating that the partnership of Ostro’s solutions and Havas’ brand expertise will help unlock new insights, modular content delivery, and optimised omnichannel performance, Yannick Bolloré, CEO and chairman of Havas, said, “We constantly seek technologies that create meaningful value for our clients. Ostro represents a leap forward in intelligent brand engagement, making this partnership a natural evolution of Havas’ Converged strategy."

Ostro's technology integrates into branded and unbranded healthcare providers (HCPs) and patient digital experiences, enabling agent-led personalised engagement. It also meets all the applicable regulatory compliances and standards. It enables organisations to connect with patients, caregivers and healthcare providers through digital channels.

“Ostro’s technology doesn’t respond with static one-size-fits-all content; it is context-enabled,” said Ahmed Elsayyad, president and co-founder, Ostro. 

The strategic investment by Havas has been part of the group’s €400 million investment in data, tech and AI over four years, as announced last year. As part of its global transformation strategy, the company had announced that it would strengthen its capabilities across media, creative, and health networks. Under this initaitive, it has been integrating AI into content creation, audience engagement, and performance measurement. This is being done by Havas across its agencies to automate workflows and improve targeting.

Source:
Campaign India

Related Articles

Just Published

1 day ago

Microsoft to retire Xandr DSP in favour of an ...

After acquiring the DSP from AT&T in 2021, Microsoft’s priorities began to shift more to the sell side, with AI at the forefront.

1 day ago

Apple leads as US dominates Kantar's Top 100 Global ...

As US brands dominate the top 10 in Kantar's BrandZ 2025 ranking, Chinese companies and APAC players like Airtel are rapidly gaining ground, signalling a shifting balance in global brand power.

1 day ago

Affordable, not cheap: Cracking the code on value

Affordable brands thrive by meeting emotional needs, using smart packaging cues, and moving beyond price cuts, explain Ipsos India’s UU and Synthesio lead and country chief client officer.

1 day ago

Rust never sleeps, but it can be outsmarted

AM/NS India’s new ad pits steel tech against cartoonish corrosion, turning rust into the most animated villain this side of Hollywood.